These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 23513882)

  • 1. [Molecular targeted therapy for gastric cancer].
    Muto O; Sakata Y
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():447-51. PubMed ID: 23513882
    [No Abstract]   [Full Text] [Related]  

  • 2. Gastric cancer: trastuzumab trial results spur search for other targets.
    Hede K
    J Natl Cancer Inst; 2009 Oct; 101(19):1306-7. PubMed ID: 19755679
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chinese expert consensus on the molecular-targeted therapy for HER-2-positive advanced gastric cancer].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):315-9. PubMed ID: 23985265
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of epidermal growth factor receptor in prognosis and treatment of gastric cancer.
    Hong L; Han Y; Brain L
    Expert Rev Gastroenterol Hepatol; 2014 Jan; 8(1):111-7. PubMed ID: 24410474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular targeting agents for advanced or recurrent gastric cancer patients].
    Fuse N
    Nihon Rinsho; 2012 Oct; 70(10):1819-26. PubMed ID: 23198568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted therapy for gastric cancer--current status.
    Kulig J; Kołodziejczyk P; Kulig P; Legutko J
    J Oncol Pharm Pract; 2013 Mar; 19(1):75-81. PubMed ID: 22711713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Targeted therapies in digestive oncology].
    Boutayeb S; Bensouda Y; Fadoulkhair Z; Bakkraoui K; Bachouchi M; Errihani H
    Pathol Biol (Paris); 2012 Aug; 60(4):264-8. PubMed ID: 22743093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular target for Her2 positive gastric cancer].
    Boku N
    Nihon Shokakibyo Gakkai Zasshi; 2012 Dec; 109(12):2014-20. PubMed ID: 23221049
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted therapies with chemoradiation in esophageal cancer: development and future directions.
    Hong TS; Wo JY; Kwak EL
    Semin Radiat Oncol; 2013 Jan; 23(1):31-7. PubMed ID: 23207045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trastuzumab plus chemotherapy in gastric cancer overexpressing HER-2 and EGFR: a case report.
    Al-Batran SE; Ruppert M; Jäger E
    Onkologie; 2011; 34(1-2):42-5. PubMed ID: 21346384
    [No Abstract]   [Full Text] [Related]  

  • 11. Targeted therapies in the treatment of gastric cancer.
    Ngeow J; Tan IB; Choo SP
    Asia Pac J Clin Oncol; 2011 Sep; 7(3):224-35. PubMed ID: 21884434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining targeted agents in lung cancer.
    Belani CP; Adjei A
    Clin Lung Cancer; 2004 Nov; 6(3):138. PubMed ID: 15555212
    [No Abstract]   [Full Text] [Related]  

  • 13. Buying time in gastric cancer.
    Nelson B
    Cancer Cytopathol; 2010 Dec; 118(6):414. PubMed ID: 21240994
    [No Abstract]   [Full Text] [Related]  

  • 14. Advances in the management of HER2-positive advanced gastric and gastroesophageal junction cancer.
    Bang YJ
    J Clin Gastroenterol; 2012 Sep; 46(8):637-48. PubMed ID: 22751336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HER-2 overexpression and targeted treatment by trastuzumab in a very old patient with gastric cancer.
    Inui T; Asakawa A; Morita Y; Mizuno S; Natori T; Kawaguchi A; Murakami M; Hishikawa Y; Inui A
    J Intern Med; 2006 Nov; 260(5):484-7. PubMed ID: 17040255
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progress of molecularly targeted therapy for breast cancer].
    Ito Y
    Rinsho Ketsueki; 2012 Apr; 53(4):426-32. PubMed ID: 22687976
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolated CNS relapse in human epidermal growth factor receptor 2-positive esophagogastric cancer: effective treatment with trastuzumab after failure of surgery and radiotherapy.
    Geldart T; Astras G
    J Clin Oncol; 2011 Aug; 29(23):e664-5. PubMed ID: 21646609
    [No Abstract]   [Full Text] [Related]  

  • 18. Advanced HER2-positive gastric cancer: current and future targeted therapies.
    Pazo Cid RA; Antón A
    Crit Rev Oncol Hematol; 2013 Mar; 85(3):350-62. PubMed ID: 23021388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and II clinical trials for gastric cancer.
    Khushalani NI
    Surg Oncol Clin N Am; 2012 Jan; 21(1):113-28. PubMed ID: 22098835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive response to trastuzumab in a case of HER2-overexpressing metastatic gastric cancer that presented as severe thrombocytopenia.
    Choi JH; Han HS; Lee HC; Lee OJ; Kim JT; Lim SN; Lee KH; Kim ST
    Onkologie; 2011; 34(11):621-4. PubMed ID: 22104159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.